Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Targeting late inflammation via complement system ameliorates TBI-induced epilepsy

Sep. 15, 2021

ZDWX-25, GSK-3beta/DYRK1A dual inhibitor with promising activity in models of AD

Sep. 15, 2021

Satellos reports preclinical data on drug candidate in mouse model of DMD

Sep. 14, 2021

Repurposing ritonavir as potential disease-modifying therapy for dystonia

Sep. 14, 2021

ARN-19702 shows broad analgesic effect in animal models of pain

Sep. 13, 2021

Metabolomics study reveals dementia-linked metabolites

Sep. 13, 2021

GeneTACs show promise for treating myotonic dystrophy type 1

Sep. 13, 2021

fMLP receptor promotes inflammatory brain injury

Sep. 10, 2021

KG207-M, a novel bifunctional fusion protein as disease-modifying therapy for AD

Sep. 10, 2021

Herantis advances project to combine Nanoform's technology with rhCDNF for Parkinson's disease

Sep. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...